KLK3 and prostate carcinoma: Two prostate-specific antigens are being explored in Phase I trials in prostate cancer thus far using PSMA and prostate stem cell antigen (PSCA), which is primarily expressed in prostate cancer cells and is expressed in advanced prostate cancer [81].